Authors:
ZIMMERMAN JE
SENEFF MG
SUN XL
WAGNER DP
KNAUS WA
Citation: Je. Zimmerman et al., EVALUATING LABORATORY USAGE IN THE INTENSIVE-CARE UNIT - PATIENT AND INSTITUTIONAL CHARACTERISTICS THAT INFLUENCE FREQUENCY OF BLOOD-SAMPLING, Critical care medicine, 25(5), 1997, pp. 737-748
Authors:
ZIMMERMAN JE
WAGNER DP
SENEFF MG
BECKER RB
SUN XL
KNAUS WA
Citation: Je. Zimmerman et al., INTENSIVE-CARE UNIT ADMISSIONS WITH CIRRHOSIS - RISK-STRATIFYING PATIENT GROUPS AND PREDICTING INDIVIDUAL SURVIVAL, Hepatology, 23(6), 1996, pp. 1393-1401
Authors:
SENEFF MG
ZIMMERMAN JE
KNAUS WA
WAGNER DP
DRAPER EA
Citation: Mg. Seneff et al., PREDICTING THE DURATION OF MECHANICAL VENTILATION - THE IMPORTANCE OFDISEASE AND PATIENT CHARACTERISTICS, Chest, 110(2), 1996, pp. 469-479
Citation: Mg. Seneff et Ra. Mathews, USE OF HALOPERIDOL INFUSIONS TO CONTROL DELIRIUM IN CRITICALLY ILL ADULTS, The Annals of pharmacotherapy, 29(7-8), 1995, pp. 690-693
Authors:
SENEFF MG
WAGNER DP
WAGNER RP
ZIMMERMAN JE
KNAUS WA
Citation: Mg. Seneff et al., HOSPITAL AND 1-YEAR SURVIVAL OF PATIENTS ADMITTED TO INTENSIVE-CARE UNITS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, JAMA, the journal of the American Medical Association, 274(23), 1995, pp. 1852-1857
Citation: Tb. Gilbert et al., FACILITATION OF INTERNAL JUGULAR VENOUS CANNULATION USING AN AUDIO-GUIDED DOPPLER ULTRASOUND VASCULAR ACCESS DEVICE - RESULTS FROM A PROSPECTIVE, DUAL-CENTER, RANDOMIZED, CROSSOVER CLINICAL-STUDY, Critical care medicine, 23(1), 1995, pp. 60-65
Authors:
BECKER RB
ZIMMERMAN JE
KNAUS WA
WAGNER DP
SENEFF MG
DRAPER EA
HIGGINS TL
ESTAFANOUS FG
LOOP FD
Citation: Rb. Becker et al., THE USE OF APACHE-III TO EVALUATE ICU LENGTH OF STAY, RESOURCE USE, AND MORTALITY AFTER CORONARY-ARTERY BYPASS-SURGERY, Journal of Cardiovascular Surgery, 36(1), 1995, pp. 1-11
Authors:
FISHER CJ
DHAINAUT JFA
OPAL SM
PRIBBLE JP
BALK RA
SLOTMAN GJ
IBERTI TJ
RACKOW EC
SHAPIRO MJ
GREENMAN RL
REINES HD
SHELLY MP
THOMPSON BW
LABRECQUE JF
CATALANO MA
KNAUS WA
SADOFF JC
ASTIZ M
CARPATI C
BONE RC
FREIDMAN B
MURE AJ
BRATHWAITE C
SHAPIRO E
MELHORN L
TAYLOR R
KEEGAN M
OBRIEN J
SCHEIN R
PENA M
WASSERLOUF M
OROPELLO J
BENJAMIN E
DELGUIDICE R
EMMANUEL G
LIE T
ANDERSON L
MARSHALL J
DEMAJO W
ROTSTEIN O
FOSTER D
ABRAHAM E
MIDDLETON H
PERRY C
LEVY H
FRY DE
SIMPSON SQ
CROWELL RE
NEIDHART M
STEVENS D
COFFMAN T
NARASIMHAM N
MERRICK DK
BERGQUIST W
MATZEL KE
HUEBLER M
FOULKE GE
ALBERTSON TE
WALBY WF
ALLEN RP
BAUGHMAN R
HASSELGREN PO
FINK MP
FAVORITO F
THOMPSON BT
CORBIN R
SHELLHORSE GY
FRAZIER A
WHITE S
GARRARD C
ACOURT C
STORER S
GERVICH DH
FOSHE D
BRASE R
BAGDAHN A
COONEY R
SMITH JS
MARTIN LF
VINCENT JL
FRIEDMAN G
BERLOT G
FLETCHER JR
WILLIAMS MD
WRIGHT TF
JOHNSON S
FEILD C
WOLF K
MACINTYRE N
DUBIN HG
DURKIN MR
DUBIN PK
STAUBACH KH
FEIN AM
SCHULMAN DB
NIEDERMAN MS
CHALFIN DB
VANLEEUWEN PAM
BOERMEESTER MA
SCHNEIDER AJ
BANDER J
IMM A
BERNARD G
NELSON L
STROUD M
SAFCSAK K
CERRA F
RINDAL J
MANN H
HALPERN N
SILVERSTEIN J
ALICEA M
SIBBALD WJ
MARTIN CM
RUTLEDGE FS
PETTI K
RUSSELL JA
KRUGER R
DRUMMOND A
LANGE P
SEIFERT T
DUROCHER A
TENAILLON A
BOITEAU R
LHERM T
LOWRY SF
COYLE SM
BARIE PS
DEMARIA E
SNYDMAN DR
SCHWAITZBERG SD
NASRAWAY SA
GRINDLINGER J
SUMMER W
DEBOISBLANC B
WAHL M
ALESTIG K
GROSSMAN J
MAKI D
PAZ HL
WEINER M
BIHARI D
CAMPBELL D
BLEICHNER G
DAHN MS
LANGE MPA
HALL J
POHLMAN A
WENZEL RP
GROSSERODE M
COSTIGAN M
MILESKI W
WEIGELT J
YESTON N
IRIZARRY C
ROSS J
ROBBINS J
NIGHTINGALE P
OWEN K
SANDSTEDT S
BERG S
SIMON GL
SENEFF MG
CONRY KM
ZIMMERMAN JL
DELLINGER RP
JOHNSTON R
ALLEE P
GRANDE PO
MYHRE E
DHAINAUT JF
HAMY I
MIRA JP
HARMON J
WHITE J
MCKIE L
SILVERMAN H
TUMA P
BENNETT D
PORTER JC
LAURELL MH
JACOBS S
ASH S
STILES DM
PRIOR MJ
KNATTERUD G
TERRIN M
KUFERA J
WILKENS P
RA K
MONROE L
SPRUNG C
HAMILTON CM
MATTHAY R
MCCABE W
TONASCIA J
WIEDEMAN H
WITTES J
CAMPION GV
CROFT CR
LUSTICK R
LOOKABAUGH J
GORDON GS
NOE L
BLOEDOW D
SMITH CG
BRANNON D
KUSH R
NG D
MOORE E
BAZEMORE K
GALVAN M
WAGNER D
HARRELL F
STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843